Indonesia
DPI’s Specialized Manufacturing Excellence
Indonesia Plants
Daewoong Pharmaceutical Indonesia (DPI) operates state-of-the-art manufacturing facilities, strategically positioned to support the growth of Indonesia’s pharmaceutical and biotechnology industry. Our plants specialize in stem cell therapies and biopharmaceuticals, ensuring high-quality production that meets the evolving needs of the Indonesian healthcare system.

In addition to our expertise in biopharmaceuticals, DPI is actively expanding its business in the cosmeceutical sector through ODM (Original Design Manufacturing) services, offering small-scale production that handles every aspect of product planning, development, production, and manufacturing to provide tailored solutions for the skincare industry.
Key Products & Capabilities
01
Stem Cells
02
Immune Cells
03
Secretome
04
Exosome
05
EGF Transfersome
Daewoong Pharmaceutical Indonesia - DPI
DPI Stem Cell Plant
Feature
Daewoong Pharmaceutical Indonesia - Surabaya Plant
Surabaya Plant
Feature
Daewoong Pharmaceutical Indonesia - DPI Chemical Plant
DPI Chemical Plant
Feature
Quality Control & Certifications
CPOB
(Stem Cell GMP Certificate)
CPKB
(Cosmetic - Semi-solid GMP Certificate)
CPKB
(Cosmetic - Liquid GMP Certificate)